As researchers race to develop a COVID-19 vaccine, two Rutgers Global Health Institute core faculty members discuss how clinical trials work, the ethics of developing and distributing a vaccine, safety and efficacy in clinical trials, and what a successful vaccine may mean.
Health officials can’t rely on a one-size-fits-all message when it comes to communicating with the public about a forthcoming COVID-19 vaccine, says Professor William Hallman, an experimental psychologist who uses scientific research to explore human behavior.
Human behavior is undermining efforts to curtail the spread of COVID-19, says School of Public Health dean and epidemiologist Perry N. Halkitis in a televised interview on CNN’s Erin Burnett OutFront nightly news program.
COVID-19 testing, HIV prevention, opioid misuse, school readiness, and urban health inequity are the focus areas of five faculty-led projects that received seed grants from Rutgers Global Health Institute.
While the overall rates of HIV/AIDS have decreased, the risk of infections within certain populations has surged. New Jersey Medical School faculty member Shobha Swaminathan is a clinical site leader for a vaccine trial that aims to provide HIV immunity for life.